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ABSTRACT Bacteria elicit an adaptive response against hostile conditions such as
starvation and other kinds of stresses. Their ability to survive such conditions de-
pends, in part, on stringent response pathways. (p)ppGpp, considered to be the
master regulator of the stringent response, is a novel target for inhibiting the sur-
vival of bacteria. In mycobacteria, the (p)ppGpp synthetase activity of bifunctional
Rel is critical for stress response and persistence inside a host. Our aim was to de-
sign an inhibitor of (p)ppGpp synthesis, monitor its efﬁciency using enzyme kinetics,
and assess its phenotypic effects in mycobacteria. As such, new sets of inhibitors tar-
geting (p)ppGpp synthesis were synthesized and characterized by mass spectrome-
try and nuclear magnetic resonance spectroscopy. We observed signiﬁcant inhibition
of (p)ppGpp synthesis by RelMsm in the presence of designed inhibitors in a dose-
dependent manner, which we further conﬁrmed by monitoring the enzyme kinetics.
The Rel enzyme inhibitor binding kinetics were investigated by isothermal titration
calorimetry. Subsequently, the effects of the compounds on long-term persistence,
bioﬁlm formation, and bioﬁlm disruption were assayed in Mycobacterium smegmatis,
where inhibition in each case was observed. In vivo, (p)ppGpp levels were found to
be downregulated in M. smegmatis treated with the synthetic inhibitors. The com-
pounds reported here also inhibited bioﬁlm formation by the pathogen Mycobacte-
rium tuberculosis. The compounds were tested for toxicity by using an MTT assay
with H460 cells and a hemolysis assay with human red blood cells, for which they
were found to be nontoxic. The permeability of compounds across the cell mem-
brane of human lung epithelial cells was also conﬁrmed by mass spectrometry.
KEYWORDS (p)ppGpp, mycobacteria, stringent response
Under stress, bacteria generate a response known as the “stringent response” toenhance their resilience under stressful and nutrient-limited conditions. This in-
volves the production and accumulation of an altered nucleic acid base, (p)ppGpp
(guanosine pentaphosphate or guanosine tetraphosphate). It is known that
(p)ppGpp has a substantial role in the regulation of many physiological processes,
including transcription, translation, replication, GTP homeostasis, viability, and viru-
lence (1–4). In Bacillus subtilis, a (p)ppGpp-null mutant failed to survive under non-
stressed conditions due to dysregulated GTP homeostasis (5).
Mycobacterium tuberculosis, the causative agent of tuberculosis (TB), is the major
pathogen responsible for human mortality in the world. Successful treatment of TB
requires the administration of multiple drugs for at least 6 months. The major reason
for this prolonged treatment of TB is the bacterium’s ability to survive in a dormant
state, which makes it tolerant to various inhibitors used in the treatment regimen.
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In mycobacteria, (p)ppGpp is synthesized and degraded by the bifunctional Rel
protein, encoded by the rel gene. When this gene was deleted in M. smegmatis and M.
tuberculosis, the knockout (KO) strains (Δrel) lost their long-term survival ability during
nutrition starvation (6, 7). In addition, the Δrel strain of M. tuberculosis was unable to
persist in mice (8) and unable to form tubercle lesions in guinea pigs (6), demonstrating
the importance of (p)ppGpp in virulence. Speciﬁcally, the synthetase activity of the
bifunctional Rel has been shown to be critical for the persistence of M. tuberculosis in
mice (9). Many studies indicate that mycobacteria lacking (p)ppGpp are defective in
bioﬁlm formation and antibiotic tolerance (9–11). Most antibiotics target cellular com-
ponents such as ribosomes and the cell wall, mainly affecting the bacterial metabolism.
However, bacteria can adjust their metabolism to survive under different conditions,
including entering a state of dormancy. Thus, there is a need to develop new inhibitor
compounds to target the “alternate adaption strategies” of dormant bacteria (10). The
stringent response is an attractive target with this goal in mind.
Active research is searching for compounds that can inhibit the synthesis of
(p)ppGpp by Rel enzyme. Recently, a molecule named Relacin has been synthesized for
inhibiting (p)ppGpp formation. It was designed based on the Rel/Spo (from Strepto-
coccus equisimilis) crystal structure, where a 2=-deoxyguanosine-based analogue of
alarmone molecule ppGpp with the original pyrophosphate moieties at positions 5=
and 3= replaced by glycyl-glycine dipeptides (12, 13). Docking studies were carried out
in which Relacin was modeled onto the Rel/SpoT synthetase site. A range of hydrogen
bonds/hydrophobic interactions and occupation of the site was taken into consider-
ation, thereby providing a structural basis for the inhibitory effect of Relacin (12, 13)
(Fig. 1). However, the efﬁciency of these analogues is not appreciable. It has been
reported that the isobutyryl group at C-2 of the guanine base in Relacin molecule is
critical for inhibition. Therefore, we decided to synthesize a more potent compound by
functionalization of the amine group at C-2 position of the guanine base in Relacin.
RESULTS
Synthesis. The amino group at the C-2 substituent of the guanine moiety in
guanosine was modiﬁed with benzoyl and acetyl groups. The 2=, 3=, and 5= positions
were protected through acetylation.
Synthesis of protected guanosine derivatives 1 and 3 were conducted as shown in
scheme 1 (Fig. 2). Peracetylation of guanosine using acetic anhydride in pyridine
afforded acetyl protected guanosine derivative 1, in a 56% yield. Incorporation of acetyl
moiety at the available hydroxyl and amine sites was veriﬁed through physical tech-
niques. The –NH proton in compound 1 resonated at 10.47 ppm as a singlet in a 1H
nuclear magnetic resonance (NMR) spectrum, whereas the anomeric carbon in com-
pound 1 resonated at 87.2 ppm in a 13C NMR spectrum. Peaks at 169.4 to 172.9 ppm
corresponded to carbonyl moieties of ester and amide functionalities in compound 1.
The molecular ion peak in compound 1 was observed at 451.97 [M] in a matrix-assisted
laser desorption ionization–time of ﬂight (MALDI-TOF) mass spectrum, as the base peak
(Fig. 3).
Similarly, benzoylation of guanosine using benzoyl chloride in pyridine led to the
formation of benzoyl protected guanosine intermediate compound 2, in 62% yield.
FIG 1 Structure of pppGpp and Relacin.
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O-debenzoylation of compound 2, by treatment with NaOH (0.1 M) in methanol
(MeOH), followed by O-acetylation using acetic anhydride in pyridine, afforded pro-
tected guanosine compound 3, in a 41% yield (scheme 1, Fig. 2). The formation of
compound 3 was conﬁrmed by NMR spectroscopy and mass spectrometry. In the
MALDI-TOF mass spectrum, the appearance of peak at 513.8 [M] and 536.04 [M Na],
as the base peak, corresponded to the molecular ion peak of compound 3 (Fig. 3). The
NH proton appeared as a broad singlet at 9.46 ppm in the 1H NMR spectrum,
attributed to benzoyl amide functionality of compound 3. In the 13C NMR spectrum of
compound 3, anomeric carbon appeared at 87.3 ppm, whereas carbonyl groups of ester
functionalities resonated in the region of 169.9 to 171.0 ppm.
AB and AC compounds inhibited the in vitro and in vivo Rel activity. In vitro
activity assays were performed in the presence of 100 M acetylated compound (AC
compound) and acetylated benzoylated compound (AB compound). At a 100 M
concentration, AC and AB compounds inhibited pppGpp synthesis by 30 and 75%,
respectively (Fig. 4). The 50% inhibitory concentration was calculated to be nearly 40
M by testing the inhibition in the presence of different doses of acetylated benzoy-
lated compounds (Fig. 4b).
Next, we studied the effects of compounds on bacterial cells in minimal medium
conditions and quantitated the in vivo (p)ppGpp levels in treated M. smegmatis cells in
comparison to the untreated cells. The synthetic compounds inhibited (p)ppGpp
synthesis in M. smegmatis. Densitometric analysis was done to check the decrease in
FIG 2 Reagents and conditions: scheme 1. (i) Acetic anhydride, 4-dimethylaminopyridine, pyridine, 0°C to room temperature, 12 h,
56%. (ii) Benzoyl chloride, 4-dimethylaminopyridine, pyridine, 0°C to room temperature, 12 h, 62%. (iii) a. Sodium hydroxide (0.1 M),
methanol, room temperature, 12 h; b. acetic anhydride, 4-dimethylaminopyridine, pyridine, 0°C to room temperature, 12 h, 41% (after
two steps). In the text, compound 1 is referred to as the acetylated compound (AC compound), and compound 3 is referred to as the
acetylated benzoylated compound (AB compound).
FIG 3 MALDI-TOF analysis of AC and AB compounds. (Top) MALDI-TOF analysis of acetylated compound (AC compound). The
451.9 m/z value corresponds to the acetylated derivative of guanosine (AC compound). (Bottom) MALDI-TOF analysis of
acetylated benzoylated guanosine (AB compound). The 513.8 m/z value corresponds to the mass of AB compound, and the
536.0 m/z value is its sodiated adduct. Intens., intensity; a.u., arbitrary units.
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(p)ppGpp levels by the application of ImageJ software. A signiﬁcant decrease in
(p)ppGpp levels was observed as determined by Student t test (Fig. 5). The AB
compound was found to be more potent in inhibiting the in vivo (p)ppGpp synthesis.
Previously, it has been reported that the mycobacterial cells devoid of the rel gene
are morphologically different and elongated (4, 14). We analyzed the average lengths
of the M. smegmatis cells treated with AB compound and found them to be elongated
(see Fig. S6 in the supplemental material), which supports alterations in (p)ppGpp
levels, indirectly.
FIG 4 (a) Inhibitory effects of AC and AB compounds on in vitro pppGpp synthesis at a 100 M concentration. Each
experiment was performed in three biological replicates. Densitometric analysis was performed, and the values
obtained were normalized with respect to the wild type (WT or 4). A Student t test was carried out to conﬁrm the
signiﬁcance. The P value was 0.05 in the case of 6 and 7. (b) Dose-dependent inhibition of in vitro pppGpp
synthesis ranging from 1 to 250 M.
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Binding kinetics by isothermal titration calorimetry. We performed a isothermal
titration calorimetry based experiment to conﬁrm the speciﬁc binding of the AB
compound to the Rel molecule. From the isothermal titration calorimetry (ITC) curve of
the Rel enzyme fromM. smegmatis with the AB compound in a range of concentrations,
a dissociation constant as 10 M (Fig. 6) was obtained. The binding was predomi-
nantly driven by enthalpy. The n value obtained was 1, signifying one binding site of
AB compound on the Rel enzyme (Fig. 6).
Enzyme kinetics of Rel. The enzyme kinetics for (p)ppGpp synthesis by RelMsm (i.e.,
the full-length Rel enzyme from M. smegmatis) in the presence of 100 M AC and AB
compounds were monitored to understand the level of inhibition in comparison to that
of the Rel control. Substrate concentrations were varied from 0 to 2,000 M for the
kinetics study of Rel in the presence of AC compound. For the AB compound, a 0 to
3,000 M range of substrate concentrations was used since a higher concentration of
substrate was required to achieve saturation. The enzyme kinetics curve was observed
to ﬁt with the Hill equation.
The K0.5 was found to increase with the concomitant reduction in the Vmax value in
the presence of AB compound. Such changes in the K0.5 and Vmax values indicate mixed
inhibition (Fig. 7). We observed that the AC compound led to an increase in the K0.5
value, without a signiﬁcant change in the Vmax value, suggesting competitive inhibition.
The Hill coefﬁcient value was observed to be more than 1 (1), indicating positive
cooperative binding where binding of one ligand molecule to the enzyme induces the
binding of other ligand molecules.
Synthetic compounds affect cell survival. (p)ppGpp synthesis is important for the
long-term survival of mycobacteria (15).Therefore, we were intrigued to look for the
effects of the synthetic compounds on M. smegmatis survival. We found signiﬁcant
inhibition of long-term survival in the presence of the compounds (100 M) in
comparison to the wild-type untreated controls (Fig. 8). Both AC and AB compounds
showed considerable inhibition. A Rel KO strain was used as a control which also
showed the decreased long-term survival as reported by others (4). We used the Rel
complemented knockout strain and found that long-term survival was restored only in
the absence of compounds.
The Rel KO did not show further inhibition of long-term survival in the presence of
the compounds (Fig. 8), supporting that Rel was the target of the compounds. Our
FIG 5 In vivo estimation of (p)ppGpp levels in M. smegmatis. The experiment was conducted in three
biological replicates. A Student t test was performed to conﬁrm the signiﬁcance. The P value was found
to be 0.05 for both the AC compound and the AB compound.
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compounds target Rel and inhibit (p)ppGpp synthesis, thereby affecting long-term
survival in M. smegmatis.
Bioﬁlm formation and quantiﬁcation. Bacterial adaptation to hostile conditions
involves the activation of cascades and transitions to resilient phenotypes such as from
planktonic to bioﬁlm forms. Bioﬁlms protect the bacteria from stress and induce
tolerance to antibiotics. Bioﬁlms are made up of microbial populations enclosed in a
matrix. Bioﬁlms are a thousand times more tolerant to antibiotics compared to the
planktonic cells (10). It has been shown that tuberculosis bacteria incapable of forming
bioﬁlms cannot survive inside the host (15). Recent evidences indicate that M. tuber-
culosis display a bioﬁlm-like phenotype during infection that could help it survive inside
the host (16). Alarmone molecule (p)ppGpp has been directly linked to bioﬁlm forma-
tion. It has been shown that M. tuberculosis and M. smegmatis rel KO strains are not
effective in forming bioﬁlms (9, 10). Therefore, (p)ppGpp formation and its associated
pathways are seen as an important drug target for bioﬁlm inhibition (17, 18).
We analyzed bioﬁlm formation in M. smegmatis in the presence of synthetic com-
pounds at 100 g/ml. A representative picture of bioﬁlm formation is shown in Fig. 9.
We also quantiﬁed the bioﬁlm in M. smegmatis in the presence or absence of the
synthetic compounds in comparison to the appropriate controls at different time points
(up to 144 h, Fig. 10). The bioﬁlm was quantiﬁed by using a crystal violet assay (19). In
FIG 6 Binding of the acetylated benzoylated compound to the Rel enzyme from M. smegmatis. An ITC
curve corresponding to the binding of the synthetic compound to the Rel enzyme at 25°C is presented
here. The upper panel shows the raw data for the titration of Rel enzyme with the AB compound, and
the lower panel indicates the integrated heat of binding obtained from the raw data. The model for
one-site binding was implicated to ﬁt the curve. The “N” represents the number of binding site that is
1, and the “K” represents the association constant (Ka). The dissociation constant, Kd, can be calculated
by reciprocating the Ka and was determined to be nearly 10 M.
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order to determine whether compounds can disrupt already formed bioﬁlms, bioﬁlm
disruption assays were performed where compounds were added just below the bioﬁlm
with the application of a 1-ml syringe after 72 h of growth. We assessed the change in
bioﬁlm morphology after 54 h of addition of the compound in comparison to the control
FIG 7 Enzyme kinetics of RelMsm. The rate of formation of ppGpp as a function of substrate GTP is shown here. (a) Formation of product with various substrate
concentrations; (b) phosphorimage data of the same. The table below quantiﬁes the K0.5 and Vmax of the reaction in the absence or presence of the synthesized
inhibitors. Lanes: -ve, negative control (assay buffer); WT, control (where inhibitor was not added); other lanes, assay mixture with increasing concentrations
of GTP. The concentration of the protein (RelMsm) was kept at 200 g/ml. A Student t test was performed to analyze the signiﬁcant change in Vmax and K0.5
values. The graph was ﬁtted using the Hill equation. The Hill coefﬁcient value was determined to be 1.89  0.17.
FIG 8 Long-term survival in the presence or absence of synthetic compounds (100 M) with Rel KO and Rel complement
controls in triplicates. This experiment was performed in three biological replicates. Inhibition was found to be signiﬁcant for
both AB and AC compounds.
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(see Fig. S7 in the supplemental material). The AB and AC compounds were found to inhibit
the formation of bioﬁlms, as well as disrupt the preformed bioﬁlms in M. smegmatis. It
should be mentioned here that both compounds were not bactericidal inM. smegmatis, as
determined by a CFU assay. In this assay, bacteria were cultured in the presence of the
synthesized compounds. The bacterial cells from the early log phase were plated
over the Luria-Bertani (LB), agar. We could not ﬁnd a signiﬁcant difference as deter-
mined by the Student t test in the CFU of treated cells in comparison to the untreated
cells. Subsequently, the effect of the compounds on bioﬁlm formation by M. tubercu-
losis was examined, and inhibition was observed, suggesting the reproducibility of
compound effects in the different mycobacterial species and possible clinical relevance
(Fig. 9).
Toxicity: hemolysis assay and microscopic studies. The effects of synthetic
compounds on healthy red blood cells (RBCs) and their toxicities were evaluated. The
compounds (at 220 g/ml) were found to be nontoxic, and the results were compa-
rable to the negative controls as presented in Fig. S8 in the supplemental material.
Healthy RBCs are biconcave in shape. The treated RBCs were analyzed under a micro-
scope to visualize morphological changes, if any. RBCs treated with the synthetic
compounds were observed to be biconcave (Fig. S8).
FIG 9 Bioﬁlm formation in the presence of AC and AB compounds (100 g/ml) compared to a control
experiment in which compound was not added to M. tuberculosis and M. smegmatis.
FIG 10 Bioﬁlm quantiﬁcation assay in the presence of compounds (100 g/ml) in Sauton’s media in three
biological replicates. Bioﬁlm formation was found to be decreased in the treated bacterial cells.
Compounds were added at the zero time point.
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Compounds were permeable to the human lung epithelial cell line. The per-
meability of compounds was tested using mass spectrometry to study drug permea-
bility across the cell membrane. Cells were treated with compounds, and the cell lysates
were analyzed using MALDI. The peaks corresponding to the compounds were absent
in the control and present in the treated sample. This experiment was performed in
three biological replicates to conﬁrm the observation. Here, the cells were washed three
times with phosphate-buffered saline (PBS) before lysis in order to prevent any carry
forward of the inhibitor present outside the cell. Compounds were not detected in the
ﬁnal PBS wash (20).
MTT toxicity assay. We performed an MTT [3-(4,5-dimethyl-2-thiazolyl)-2,5-
diphenyl-2H-tetrazolium bromide] assay to check the cell cytotoxicity in the presence
of the inhibitors. Here, cells with media were taken as the control and compared to the
sample (cell  media  compound) incubated for 36 h. Two concentration ranges, 100
to 500 g/ml and 100 to 400 g/ml, were tested for acetylated and acetylated
benzoylated compounds, respectively. No cytotoxicity was observed for the treated
samples, and they were comparable to the control (Fig. 11). The percent survival was
calculated to be95% up to a concentration of 400 g/ml for both tested compounds.
DISCUSSION
Unlike the exponential phase, the stationary phase of bacteria is characterized by a
low rate of translation, transcription, and replication (21). Therefore, many antibiotics
that target these pathways are virtually ineffective in the stationary phase. Further,
bacteria exposed to hostile conditions such as nutritional starvation and other kinds of
stresses induce the stringent response, which is mediated by (p)ppGpp and helps the
bacteria survive under such conditions (10). Antimicrobials that target stress induced
stringent response pathways are very few; thus, such an approach offers a unique
possibility (22).
FIG 11 MTT assay results in the presence of a range of concentrations of synthetic compounds using the
H460 cell line. The x axis indicates the concentration of the compound; the y axis indicates the
absorbance at 570 nm. (a) Acetylated benzoylated (AB) compound; (b) acetylated (AC) compound.
Stress Response Inhibitor in Mycobacteria Antimicrobial Agents and Chemotherapy
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(p)ppGpp analogues such as Relacin have been shown to be effective in inhibiting
ppGpp synthesis, stress responses, and key survival processes such as sporulation (12).
In the latter study, it has been indicated that the isobutyryl group at the second
position of guanine is critical for inhibition. We substituted it for the bulkier benzoyl
group, as well as for the smaller acetyl group. We found the benzoyl group to be better
a substituent for inhibition. Based on docking studies, we found the benzoyl ring at the
C-2 position of the guanine base to be involved in a stacking interaction with the lysine
residue at position 251 of the Rel enzyme from S. equisimilis (Fig. 12). The latter lysine
residue was found to be conserved in the Rel enzyme from mycobacteria (see Fig. S9
in the supplemental material).
We have shown here that (p)ppGpp analogs can be used to inhibit (p)ppGpp
synthesis in acid-fast bacteria such as mycobacteria. Earlier, bioﬁlm formation has been
shown to be defective in a Rel mutant strain of M. smegmatis, and bacterial cells were
found to be elongated (14). As expected, cells treated with the compounds used here
were not able to form bioﬁlm and were elongated, which is consistent with studies in
the Rel mutant (14). The long treatment regime, antibiotic tolerance, and the emer-
gence of multiple drug resistance in M. tuberculosis are attributed to its stress response
(15). It is now well known that the bacterial strains with defective (p)ppGpp synthesis
are metabolically compromised (1). Recent studies have suggested that the inhibition
of (p)ppGpp production would have a detrimental effect on bacterial survival and
virulence (9). Inhibition of the stringent response appears to be a promising approach
to controlling pathogens, such as M. tuberculosis, the causative agent of tuberculosis,
which is also known to persist inside the host. We observed that compounds were
nontoxic, as demonstrated by the MTT assay and the RBC hemolysis assay. Also,
compounds were found to be permeable to the cell membranes, as evidenced by the
detection of synthetic compounds in cell lysates by mass spectrometry.
We monitored the enzyme kinetics for Rel from M. smegmatis and, interestingly,
observed them to ﬁt according to the Hill equation. Although the inhibition exhibited
by these compounds is in the micromolar range, this suggests a novel strategy, in
which the stress response of one of the most persistent pathogens, M. tuberculosis, can
be potentially targeted. In the future, these compounds will be further improved by
modiﬁcations in order to achieve the inhibition in nanomolar range and consequently
evaluated for their use in humans.
FIG 12 The crystal structure of Relseq385, Rel/Spo from S. equisimilis, was utilized for in silico docking. The GDP molecule was removed from the active site of
the protein structure. The acetylated benzoylated compound structure (in a low energy state) was positioned at the active site in place of GDP, and all of the
rotatable bonds were kept ﬂexible. (A) Two-dimensional representation of the interactions at the active site. The red line indicates the stacking interaction,
whereas the purple dotted line shows hydrogen bonding. (B) Three-dimensional depiction of the active site with bound acetylated benzoylated compound.
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MATERIALS AND METHODS
Synthesis. All chemicals were purchased from Sigma-Aldrich and used without further puriﬁcation.
Solvents were dried and distilled before use. Silica gel (100 to 200 mesh and 230 to 400 mesh) was used
for column chromatography, and thin-layer chromatography (TLC) analysis was performed on commer-
cial plates coated with silica gel 60 F254. Visualization of the spots on TLC plates was achieved by UV
radiation or spraying 5% sulfuric acid in ethanol. High-resolution mass spectra were obtained from a
Q-TOF instrument by electrospray ionization (ESI) and MALDI-TOF. 1H and 13C NMR spectral analyses
were performed on a spectrometer operating at 400 and 100 MHz, respectively. Chemical shifts are
reported with respect to tetramethylsilane for 1H NMR and the central line (77.0 ppm) of CDCl3 for 13C
NMR spectroscopy. Coupling constants (J) are reported in Hz. Standard abbreviations s, d, t, dd, br s, and
m refer to singlet, doublet, triplet, doublet of doublet, broad singlet, and multiplet, respectively.
(i) N2,2=,3=,5=-O-Tetraacetylguanosine (compound 1). Acetic anhydride (0.4 ml, 4.24 mmol) and
4-dimethylamino pyridine (0.009 g, 0.071 mmol) were added to a suspension of guanosine (0.2 g, 0.71
mmol) in pyridine (2 ml) at 0°C, stirred for 12 h at room temperature. The reaction mixture was diluted
with CH2Cl2 (40 ml), washed with dilute aqueous HCl (2  10 ml), saturated aqueous NaHCO3 (1  10
ml), and brine (10 ml), dried (Na2SO4), ﬁltered, and concentrated in vacuo, and puriﬁed (SiO2) (ethyl
acetate [EtOAc]) to afford compound 1 (0.18 g, 56%); 1H NMR (CDCl3, 400 MHz)  12.15 (br s, 1 H), 10.47
(s, 1 H), 7.77 (s, 1 H), 5.90 to 5.86 (m, 2H), 5.54 (t, J 	 4.5Hz, 1 H), 4.42 (dd, J 	 4.5 Hz, 11.6 Hz, 1 H), 4.33
(dd, J 	 4.8 Hz, 10 Hz, 1 H), 4.23 (dd, J 	 5.8 Hz, 11.6 Hz, 1 H), 2.25 (s, 3 H), 2.04 (s, 3 H), 2.00 (s, 3 H),
1.99 (s, 3 H); 13C NMR (CDCl3, 100 MHz)  172.9, 170.9, 169.6, 169.4, 155.6, 147.9, 138.4, 121.8, 87.2, 79.8,
72.6, 70.6, 63.0, 24.1, 20.6, 20.4, 20.2; HRMS (ESI/TOF-Q) m/z: calculated for C18H21N5O9Na 	 474.1237,
found 474.1236 [M  Na], 925.2655 [2M  Na].
(ii) N2,2=-O,3=-O,5=-O-Tetrabenzoylguanosine (compound 2). Benzoyl chloride (0.98 ml, 8.5 mmol)
and DMAP (0.017 g, 0.14 mmol) was added to a suspended solution of guanosine (0.4 g, 1.41 mmol) in
pyridine (3 ml) at 0°C and stirred for 12 h at room temperature. The reaction mixture was diluted with
CH2Cl2 (60 ml), washed with dilute aqueous HCl (2 20 ml), saturated aqueous NaHCO3 (1 20 ml), and
brine (20 ml), dried (Na2SO4), ﬁltered and concentrated in vacuo and puriﬁed (SiO2) (petroleum ether:
EtOAc 	 1:1) to afford compound 2 (0.62 g, 62%); 1H NMR (CDCl3, 400 MHz)  11.94 (br s, 1 H), 9.53 (s,
1H), 8.15 (d, J 	 7.6 Hz, 2 H), 7.97 (d, J 	 6.8 Hz, 4 H), 7.84 (s, 1 H), 7.73 (d, J 	 7.2 Hz, 2 H), 7.69 (d, J 	
7.2 Hz, 1 H), 7.59 (t, J 	 7.8 Hz, 4 H), 7.52 to 7.47 (m, 1 H), 7.44 (d, J 	 8 Hz, 2 H), 7.40 (d, J 	 8 Hz, 2
H), 7.23 (d, J 	 7.6 Hz, 2 H), 6.92 (dd, J 	 5.2 Hz, 7.6 Hz, 1 H), 6.45 (dd, J 	 2 Hz, 5.2 Hz, 1 H), 6.18 (d,
J 	 2 Hz, 1 H), 4.89 to 4.83 (m, 2 H), 4.78 to 4.74 (m, 1 H); 13C NMR (CDCl3, 100 MHz)  167.3, 166.3, 166.0,
165.1, 155.2, 147.5, 139.0, 133.9, 133.8, 133.6, 131.6, 129.8, 129.7, 129.2, 129.0, 128.8, 128.7, 128.6, 128.5,
128.4, 128.3, 128.0, 122.3, 88.0, 79.3, 74.2, 70.7, 61.5; ESI-MSm/z: calculated for C38H29N5O9Na	 722.1863
[M  Na], found 722.1865.
(iii) N2-Benzoyl-2=,3=,5=-O-triacetylguanosine (compound 3). Aqueous NaOH (2 M) (0.1 ml) was
added to a solution of compound 2 (0.3 g, 0.43 mmol) in MeOH (2 ml), stirred for 12 h at room
temperature, neutralized with Amberlite ion (H) exchange resin, ﬁltered, and concentrated in vacuo.
Acetic anhydride (0.19 ml, 2.05 mmol) and 4-dimethylamino pyridine (0.005 g, 0.041 mmol) were added
to the resulting product (0.16 g, 0.41 mmol) in pyridine (2 ml) at 0°C, stirred for 12 h at room temperature.
The reaction mixture was diluted with CH2Cl2 (40 ml), washed with dilute aqueous HCl (2  10 ml),
saturated aqueous NaHCO3 (1  10 ml) and brine (10 ml), dried (Na2SO4), ﬁltered and concentrated in
vacuo and puriﬁed (SiO2) (petroleum ether:EtOAc 	 2:3) to afford compound 3 (0.09 g, 41%, after two
steps); 1H NMR (CDCl3, 400 MHz)  12.2 (br s, 1 H), 9.46 (br s, 1 H), 8.02 (d, J 	 8 Hz, 2 H), 7.72 (br s, 1
H), 7.59 (t, J 	 7.3 Hz, 1 H), 7.48 (t, J 	 7.3 Hz, 2 H), 5.99 to 5.87 (m, 3 H), 4.47 (dd, J 	 3.4 Hz, 11.5 Hz,
1 H), 4.43 to 4.39 (m, 1 H), 4.35 (dd, J 	 5.6 Hz, 11.5 Hz, 1 H), 2.10 (s, 3 H), 2.05 (s, 3 H), 1.97 (s, 3 H); 13C
NMR (CDCl3, 100 MHz)  171.0, 169.9, 167.8, 155.4, 147.9, 133.8, 131.3, 129.0, 127.9, 87.2, 79.5, 72.9, 70.7,
62.8, 20.7, 20.6, 20.4; HRMS (ESI/TOF-Q) m/z: calculated for C23H23N5O9Na 	 536.1393, found 536.1392
[M  Na], 1049.3358 [2M  Na].
The acetylated compound and the acetylated benzoylated compound were soluble in water up to 1
and 0.4 mg/ml, respectively. Both compounds were obtained as white powder.
Isothermal titration calorimetry. ITC analysis was conducted on a ITC200 Micro-Calorimeter (GE
Healthcare). The Rel enzyme (protein) was added into the cell component (200 l), and the syringe (40
l) was ﬁlled by the acetylated benzoylated (AB) compound (ligand). Protein was quantiﬁed by using a
Bradford assay. Protein and ligand were prepared in the same buffer (20 mM Tris-HCl [pH 7.9] and 50 mM
NaCl). Protein concentrations from 5 to 40 M and ligand concentrations from 125 to 700 M were used
in all experiments. The data obtained were ﬁtted using a single-binding-site model by Origin software
(v7.0; MicroCal). The ﬁrst data point was deleted, and the ligand buffer control accounting for the heat
of dilution (of ligand) was subtracted. Peak integration and the calculation of stoichiometry, Ka, and other
parameters were also accomplished using Origin software. The experiments were reproduced three
times.
Activity assay. pET 21b plasmid containing Rel cassette was used for Rel protein preparation.
Escherichia coli DH5 and E. coli BL21(DE3) were utilized for plasmid puriﬁcation and protein overex-
pression and puriﬁcation, respectively. The identity of protein and its purity was conﬁrmed by SDS-PAGE
analysis, followed by mass spectrometry (23). To trace pppGpp synthesis, [-32P]ATP (125 Ci, 3,500 Ci
mmol1) was added to an assay mixture containing 200 g of puriﬁed Rel full-length protein, 1 mM
nonradioactive ATP, 50 mM HEPES (pH 7.4), 5 mM MgCl2, 50 mM NaCl, and 1 mM GTP in a reduced
condition, as described previously (24–26). The compounds were added to the reaction mixture at the
zero time point. The protein was precipitated by heating at 95°C for 5 min, and the reaction mixture was
then subjected to centrifugation at 14,000 rpm. The supernatant was loaded on a polyethyleneimine
Stress Response Inhibitor in Mycobacteria Antimicrobial Agents and Chemotherapy
June 2017 Volume 61 Issue 6 e00443-17 aac.asm.org 11
 o
n
 June 1, 2017 by W
ashington University in St. Louis
http://aac.asm
.org/
D
ow
nloaded from
 
cellulose sheet for TLC analysis, followed by phosphorimaging (Bio-Rad-PharosFX Plus molecular imager).
The pppGpp spot was analyzed by densitometric analysis using ImageJ software (National Institutes of
Health), and the levels of pppGpp were determined.
Enzyme kinetics. Rel from M. smegmatis is a bifunctional protein with both (p)ppGpp synthesis and
hydrolysis activities. We quantiﬁed the synthesis activity of the enzyme in the presence of synthetic
compounds. The Vmax and K0.5 values were derived from the steady-state kinetic experiments for the
full-length Rel protein. The radioactive pppGpp spots were quantiﬁed as described previously, and
the standard curve was plotted (11, 27). Kinetic parameters, such as K0.5 and Vmax, were calculated using
the Hill equation. A pppGpp synthesis assay was carried out using a range of substrate (GTP) concen-
trations in order to monitor the enzyme kinetics. A substrate (GTP) concentration range of 0 to 3,000 M
was used for the acetylated benzoylated (AB) compound, whereas in the case of the control and
acetylated (AC) compound, the substrate concentration varied from 0 to 2,000 M. The range was
adjusted to achieve saturation. K0.5 and Vmax values derived from the enzyme kinetics in the presence of
compounds were compared to the values obtained from enzyme kinetics in the absence of compounds.
An assay mixture without enzyme was taken as the negative control.
In vivo quantiﬁcation assay for (p)ppGpp synthesis. M. smegmatis mc2155 strain was cultured in
the presence of AB and AC compounds to an optical density at 600 nm (OD600) of 0.2 in 5 ml of 1
morpholinepropanesulfonic acid (MOPS) deﬁned medium supplemented with 80 g/ml Casamino Acids,
0.05% Tween 80, and 2% glucose at 37°C with agitation. Cultures were radiolabeled by adding
[o-32P]phosphoric acid (speciﬁc activity, 3,000 mCi/mmol; Board of Radiation and Isotope Technology,
India) directly to the growth medium to a ﬁnal concentration of 100 Ci/ml. The cells were harvested at
72 h of growth, followed by lyophilization. Equal amounts of cells were suspended in 20 l of 1 MOPS
solution. The cells were lysed by the addition of 12 N formic acid and stored on ice for 20 min. The sample
was subjected to centrifugation at 13,000 rpm and 4°C for 10 min. Then, 2 l of supernatant, normalized
to an OD260 of 2.0, was spotted onto a polyethylenimine-cellulose sheet (Merck) for TLC analysis (1.5 M
KH2PO4 [pH 3.4]) (27). The TLC sheets were air dried and phosphorimaged, and the (p)ppGpp spots were
examined by densitometry as described previously. The identity of the spots was further conﬁrmed by
MALDI-TOF mass spectrometry.
Long-term survival assay. Strains were cultured in MB7H9 medium containing 0.02% (wt/vol)
glucose and 0.05% (vol/vol) Tween 80 in the presence or absence of the compounds (100 M) of interest.
The antibiotics were not used in the culture in order to rule out their effects on long-term survival. The
CFU were estimated at regular time intervals for 14 days. Bacterial cultures were vortexed before plating
on an MB7H9 agar plate to prevent the aggregation of cells.
Bioﬁlm formation assay. For bioﬁlm assay, M. smegmatis mc2155 was grown in Sauton’s medium
supplemented with 2% glycerol and 0.05% Tween 80 and utilized as the primary culture. The procedure
was followed as illustrated elsewhere (28–31). Brieﬂy, fully grown primary culture was washed with
Sauton’s media and then used as a secondary inoculum. Bioﬁlm was cultured in a six-well cell culture
plate (Laxbro) in which the primary inoculum was 100-fold diluted with Sauton’s medium. Inhibitors (100
g/ml) were added at the zero time point. Culture plates were incubated in a humidiﬁed incubator set
at 37 °C and evaluated at different time points.
M. tuberculosis Erdman bioﬁlms were inoculated with stationary-phase planktonic cultures into
Sauton’s medium at a 1:100 dilution in 96-well plates to a ﬁnal volume of 200 l per well. Bioﬁlm cultures
were incubated in airtight plastic bags to restrict oxygen for 3 weeks and then vented. The compounds
were added to the bioﬁlm cultures at the time of inoculation at the indicated concentrations. Photo-
graphs of bioﬁlms were taken at the times indicated.
Bioﬁlm quantiﬁcation. The bioﬁlm formation was quantiﬁed in 96-well plates, and the protocol
followed was as described previously (31). Brieﬂy, primary culture was washed and resuspended in
Sauton’s medium to an OD590 of 0.0025. The inhibitors were added to the well containing 200 l of
inoculum at the zero time point, and bioﬁlm formation was monitored for up to 144 h. The medium was
removed from the wells, followed by washing with water. Subsequently, staining solution (1% crystal
violet, 200 l) was added to each well, and each plate was incubated for 20 min. The wells were washed
with water and dried. The dye was quantitated after solubilization in dimethyl sulfoxide (DMSO; 200 l),
and the absorption at 590 nm was then recorded using a microplate reader. This experiment was
performed in three biological replicates for each inhibitor.
Bioﬁlm disruption assay. In this assay, M smegmatis mc2155 was allowed to form a bioﬁlm in
Sauton’s medium in a 6-well plate at 37°C humidiﬁed incubator as described earlier. Inhibitors were
administered below the bioﬁlm at 72 h by using 1-ml syringe. Bioﬁlm growth was monitored until the
126-h time point, and the plates were monitored for bioﬁlm disruption. This experiment was conducted
in three biological replicates
Hemolysis assay and microscopy. Hemolysis of human RBCs was monitored in the presence of
synthetic compounds. Left over blood sample obtained from Health Center, Indian Institute of Science,
Bangalore, India, was used for this study. Hemolysis assays were performed as described elsewhere (32).
Brieﬂy, each blood sample was pelleted by centrifugation (500  g, 10 min), and supernatant (plasma)
was gently removed (treated with bleach and discarded into biohazardous wastes). The RBC pellet was
washed and resuspended in PBS (pH 7.4). An assay was performed at various concentrations of inhibitors
(10 l, 20 to 220 g/ml) mixed with 190 l of diluted RBCs (1:20 dilution) in a 96-well plate. Then, 10 l
of 20% sodium dodecyl sulfate was used in a positive-control well, and 10 l of phosphate buffer was
used as the negative control. The plate was incubated at 37°C for 1 h, and then 100 l of the supernatant
was transferred into Eppendorf tubes, followed by centrifugation for 10 min at 500  g. The supernatant
was transferred into a fresh Eppendorf tubes, and the absorbance of the supernatant was measured at
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540 nm in a UV/visible spectrophotometer (Eppendorf). This experiment was performed in triplicates.
RBCs treated with synthetic compounds were observed under a light microscope at 40 magniﬁcation.
These RBCs, suspended in PBS, were poured onto a slide, covered with a coverslip, cleaned, and placed
under a microscope.
Cell culture. The human lung epithelial cell line was cultured in Roswell Park Memorial Institute 1640
(RPMI 1640) medium supplemented with 10% fetal bovine serum. The cultures were grown in a
humidiﬁed atmosphere with 5% CO2 in an incubator at 37°C for 2 to 3 days. At nearly 80% conﬂuence,
the medium was removed, and the cells were washed with PBS and detached using 0.25% trypsin-EDTA
at 37°C for 2 to 3 min. Subsequently, 1 ml of fresh medium was added. The cells were pelleted down at
1,000 rpm for 5 min and resuspended in fresh medium (10 ml) in a tissue culture ﬂask. The cells were
mixed with trypan blue in a 1:1 ratio and observed using hemocytometer under a microscope in order
to check the cell count.
Cell permeability assay. Cell suspensions (nearly 2,500 cells, 0.2 ml) were added to each well of a
96-well plate, followed by incubation for 24 h for adherence. The culture medium was replaced with fresh
medium with compounds at a concentration of 200 g/ml. The cells were incubated for 6 h, the medium
was removed, and the cells were washed with PBS. Adhered cells were removed using 0.25% trypsin-
EDTA, and the cells were washed three times with PBS. The cell pellet was resuspended in 50 l of PBS.
Cells were lysed by heating them at 95°C for 10 min, followed by centrifugation at 15,000 rpm for 10 min.
This soup was transferred to a labeled tube and analyzed by mass spectrometry.
Mass spectrometry.MALDI was used for the peak identiﬁcation of drugs. A 1-l portion of cell lysate
mixed with 1 l of CCA (-cyano-4-hydroxycinnamic acid) was spotted onto a plate and allowed to dry.
Mass spectra were recorded on Ultraﬂex II MALDI-TOF/TOF mass spectrometer equipped with a Smart-
Beam (Bruker Daltonik, Germany) operated in positive-ion, reﬂectron mode. Three to ﬁve mass spectra
were recorded and averaged for each individual sample using 1,000 to 1,500 laser shots over the entire
spot on the MALDI target plate. A PBS wash was taken as the negative control.
MTT assay. The effect of inhibitors on cell viability was studied using an MTT assay. This is a
colorimetric assay, which measures the metabolic activity of the cell as a function of reduction of
tetrazolium dye to insoluble formazan. H460 cell lines were used to determine the cytotoxicity. Cell
suspensions (nearly 2,500 cells, 0.2 ml) were seeded into 96-well plates and incubated for 24 h for the cells
to adhere. After this culture, the medium was replaced with fresh medium with the inhibitors in a concen-
tration range of 100 to 500 g/ml. This experiment was conducted in three biological replicates for each
concentration of the inhibitor. After 36 h of incubation, 20 l of MTT at a concentration of 0.5 mg/ml was
added to each well, followed by incubation for 4 h. Later, the medium was removed, and the cells were
washed with PBS. Then, 100 l of DMSO was used to dissolve the formazan crystal, followed by measuring
the absorbance at 570 nm using an enzyme-linked immunosorbent assay plate reader. Medium alone and
medium with cells (without inhibitor) were used as controls. The percentage of cell survival was calculated
using the following formula: cell survival (%) 	 (AbsorbanceTreatment/AbsorbanceControl)  100.
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